BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Nektar Therapeutics (CA) to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets

  November 7, 2012

   · 

  2 min read
• Genetown

  Synageva BioPharma to Present at Upcoming Investor Conferences

  November 7, 2012

   · 

  1 min read
• Policy

  NanoSight Limited Joins the EU Methods List Relating to “Nanomaterials”

  November 7, 2012

   · 

  4 min read
• Business

  Ariad Pharmaceuticals, Inc. Reports Third Quarter 2012 Financial Results and Development Progress

  November 7, 2012

   · 

  1 min read
• Business

  AxoGen, Inc. Announces Third Quarter 2012 Financial Results

  November 7, 2012

   · 

  1 min read
• Drug Development

  Synta Pharmaceuticals Release: Interim Results of the Phase 2b GALAXY Trial to be Presented at the Chemotherapy Foundation Symposium

  November 7, 2012

   · 

  1 min read
• Drug Development

  Senesco Technologies, Inc. Announces Expansion of Phase 1b/2a Study to Include Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

  November 7, 2012

   · 

  1 min read
• Business

  Lota S. Zoth Joins NewLink Genetics’s Board of Directors; Heads Audit Committee

  November 7, 2012

   · 

  2 min read
• BioCapital

  Sucampo Pharmaceuticals, Inc. Announces Webcast of its Presentation at the 2012 Credit Suisse Healthcare Conference

  November 7, 2012

   · 

  1 min read
• Business

  TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2012 Financial Results

  November 7, 2012

   · 

  1 min read